AMN Healthcare Announces CFO Transition
AMN Healthcare Services, Inc. (NYSE: AMN) announced that Jeffrey Knudson will step down as Chief Financial Officer on November 8, 2024, to pursue an opportunity outside the healthcare staffing industry. The company expects to announce a new leader in an expanded Chief Financial Officer/Chief Operating Officer role before Knudson's departure.
AMN's President and CEO, Cary Grace, thanked Knudson for his leadership over the past three years. Knudson expressed confidence in the team's capabilities and the company's future positioning. AMN also reaffirmed its financial guidance for the third quarter of 2024, which was previously provided on August 8, 2024. The company will report its Q3 2024 financial results on November 7, 2024.
AMN Healthcare Services, Inc. (NYSE: AMN) ha annunciato che Jeffrey Knudson si dimetterà dal ruolo di Chief Financial Officer l'8 novembre 2024 per perseguire un'opportunità al di fuori dell'industria del personale sanitario. L'azienda prevede di annunciare un nuovo leader in un ruolo ampliato di Chief Financial Officer/Chief Operating Officer prima della partenza di Knudson.
Il Presidente e CEO di AMN, Cary Grace, ha ringraziato Knudson per la sua leadership negli ultimi tre anni. Knudson ha espresso fiducia nelle capacità del team e nella posizione futura dell'azienda. AMN ha anche ribadito le proprie aspettative finanziarie per il terzo trimestre del 2024, già fornite l'8 agosto 2024. L'azienda pubblicherà i risultati finanziari del Q3 2024 il 7 novembre 2024.
AMN Healthcare Services, Inc. (NYSE: AMN) anunció que Jeffrey Knudson renunciará como Director Financiero el 8 de noviembre de 2024 para buscar una oportunidad fuera de la industria de contratación de personal de salud. La compañía espera anunciar un nuevo líder en un cargo ampliado de Director Financiero/Director de Operaciones antes de la salida de Knudson.
El Presidente y CEO de AMN, Cary Grace, agradeció a Knudson por su liderazgo durante los últimos tres años. Knudson expresó su confianza en las capacidades del equipo y en la futura posición de la compañía. AMN también reafirmó sus previsiones financieras para el tercer trimestre de 2024, que se proporcionaron previamente el 8 de agosto de 2024. La compañía informará sus resultados financieros del Q3 2024 el 7 de noviembre de 2024.
AMN Healthcare Services, Inc. (NYSE: AMN)는 제프리 크누드슨이 재무책임자 직에서 물러난다고 발표했습니다. 재무책임자 직은 2024년 11월 8일에 물러나며, 의료 인력 산업 외부의 기회를 추구할 예정입니다. 회사는 크누드슨의 퇴직 전에 확대된 재무책임자/운영책임자 역할을 맡을 새 리더를 발표할 것으로 예상하고 있습니다.
AMN의 회장 겸 CEO인 캐리 그레이스는 지난 3년간의 크누드슨의 리더십에 감사의 뜻을 전했습니다. 크누드슨은 팀의 역량과 회사의 미래 포지셔닝에 대한 신뢰를 표명했습니다. AMN은 또한 2024년 3분기 재무 가이던스를 재확인했습니다, 이는 2024년 8월 8일에 이전에 제공된 내용입니다. 회사는 2024년 11월 7일에 Q3 2024 재무 결과를 발표할 예정입니다.
AMN Healthcare Services, Inc. (NYSE: AMN) a annoncé que Jeffrey Knudson quittera son poste de Directeur Financier le 8 novembre 2024 pour poursuivre une opportunité en dehors de l'industrie du personnel de santé. L'entreprise s'attend à annoncer un nouveau leader dans un rôle élargi de Directeur Financier/Directeur des Opérations avant le départ de Knudson.
Le Président et CEO d'AMN, Cary Grace, a remercié Knudson pour son leadership au cours des trois dernières années. Knudson a exprimé sa confiance dans les capacités de l'équipe et dans le positionnement futur de l'entreprise. AMN a également réaffirmé ses prévisions financières pour le troisième trimestre de 2024, qui avaient été fournies précédemment le 8 août 2024. L'entreprise publiera ses résultats financiers du T3 2024 le 7 novembre 2024.
AMN Healthcare Services, Inc. (NYSE: AMN) gab bekannt, dass Jeffrey Knudson als Chief Financial Officer zurücktritt am 8. November 2024, um eine Gelegenheit außerhalb der Gesundheitspersonalbranche zu verfolgen. Das Unternehmen plant, vor Knudsons Abgang einen neuen Führer in einer erweiterten Rolle als Chief Financial Officer/Chief Operating Officer bekannt zu geben.
Der Präsident und CEO von AMN, Cary Grace, bedankte sich bei Knudson für seine Führung in den letzten drei Jahren. Knudson äußerte sein Vertrauen in die Fähigkeiten des Teams und die zukünftige Positionierung des Unternehmens. AMN bestätigte auch die finanziellen Prognosen für das dritte Quartal 2024, die zuvor am 8. August 2024 bereitgestellt wurden. Das Unternehmen wird seine Finanzergebnisse für das dritte Quartal 2024 am 7. November 2024 bekannt geben.
- AMN plans to expand the CFO role to include COO responsibilities
- Company reaffirmed its Q3 2024 financial guidance
- CFO Jeffrey Knudson is leaving the company
Jeffrey Knudson to Step Down as CFO Following Company’s Q3 Report
Company Expects to Announce New Leader in Expanded CFO/COO Role Prior to November 8
Reaffirms Third Quarter 2024 Outlook
DALLAS, Oct. 01, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN) (“AMN” or “the Company”), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced that Jeffrey Knudson will step down from his role as Chief Financial Officer, effective November 8, 2024, to pursue an opportunity with a private company outside of the healthcare staffing industry.
AMN expects to announce a new leader in an expanded Chief Financial Officer/Chief Operating Officer position prior to Mr. Knudson’s departure.
Cary Grace, President and Chief Executive Officer of AMN, said, "On behalf of the AMN Board and management team, I want to thank Jeff for his leadership of our finance organization. He played an important role guiding AMN through a wide range of market conditions over his three years as our CFO. We wish him success in his new position."
Mr. Knudson said, "It has been an honor to be part of AMN and I have full confidence in the team’s capabilities. I believe the Company is well positioned to capitalize on the opportunities that lie ahead."
Reaffirms Third Quarter 2024 Outlook
AMN today reaffirmed its financial guidance for the third quarter 2024, which the Company provided in connection with the announcement of its second quarter 2024 financial results on August 8, 2024.
AMN will report its third quarter 2024 financial results on November 7, 2024.
About AMN Healthcare
AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations across the United States. Through a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated and customizable suite of workforce technologies.
The Company’s common stock is listed under the symbol “AMN” on the New York Stock Exchange. For more information about AMN Healthcare, visit www.amnhealthcare.com, where the Company posts news releases, investor presentations, webcasts, SEC filings and other material information. The Company also utilizes email alerts and Really Simple Syndication (“RSS”) as routine channels to supplement distribution of this information. To register for email alerts and RSS, visit http://ir.amnhealthcare.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning the timing of Mr. Kundson’s departure from the Company, the timing of an interim or permanent successor, our third quarter 2024 financial guidance, including consolidated and segment revenue, consolidated gross margin, operating margin, SG&A as a percent of revenue, adjusted EBITDA margin, depreciation expense, non-cash amortization expense, share-based compensation expense, integration and other expenses, interest expense, adjusted tax rate, and number of diluted shares outstanding. The Company bases these forward-looking statements on its current expectations, estimates and projections about future events and the industry in which it operates using information currently available to it. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are also identified by words such as “believe,” "project," “anticipate,” “expect,” “intend,” “plan,” “will,” “may,” “estimates,” variations of such words and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements.
For a discussion of additional risk factors and a more complete discussion of some of the cautionary statements noted above that could cause actual results to differ from those implied by the forward-looking statements contained in this press release, please refer to our most recent Annual Report on Form 10-K for the year ended December 31, 2023. Be advised that developments subsequent to this press release are likely to cause these statements to become outdated and the Company is under no obligation (and expressly disclaims any such obligation) to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise.
Media Contact
Corporate Communications
AMN Healthcare
AMN-PR@amnhealthcare.com
Investor Contact
Randle Reece
Senior Director, Investor Relations & Strategy
AMN Healthcare
(866) 861-3229
ir@amnhealthcare.com
FAQ
When will Jeffrey Knudson step down as CFO of AMN Healthcare (NYSE: AMN)?
What new role is AMN Healthcare (NYSE: AMN) planning to introduce?
When will AMN Healthcare (NYSE: AMN) report its Q3 2024 financial results?
Has AMN Healthcare (NYSE: AMN) changed its financial guidance for Q3 2024?
